Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Non-Current Assets (2021 - 2025)

Bioregenx (BRGX) has 5 years of Non-Current Assets data on record, last reported at $894608.0 in Q3 2025.

  • For Q3 2025, Non-Current Assets fell 94.73% year-over-year to $894608.0; the TTM value through Sep 2025 reached $2.2 million, changed N/A, while the annual FY2024 figure was $200739.0, 534.45% up from the prior year.
  • Non-Current Assets reached $894608.0 in Q3 2025 per BRGX's latest filing, down from $900985.0 in the prior quarter.
  • Across five years, Non-Current Assets topped out at $18.1 million in Q1 2024 and bottomed at $31640.0 in Q4 2023.
  • Average Non-Current Assets over 5 years is $4.3 million, with a median of $188362.0 recorded in 2025.
  • Peak YoY movement for Non-Current Assets: soared 51040.25% in 2024, then tumbled 98.96% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $103404.0 in 2021, then plummeted by 43.45% to $58473.0 in 2022, then crashed by 45.89% to $31640.0 in 2023, then soared by 534.45% to $200739.0 in 2024, then soared by 345.66% to $894608.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Assets were $894608.0 in Q3 2025, $900985.0 in Q2 2025, and $188362.0 in Q1 2025.